Category: Saladax Biomedical

Saladax Licenses Alzheimer’s Diagnostic Tests to Siemens Healthineers

Yahoo Finance • January 18, 2017

Saladax Biomedical, Inc., a privately held company focused on precision in-vitro diagnostic tests, announced today that it has signed an agreement to license diagnostic tests for Alzheimer’s disease (AD) to Siemens Healthineers. Saladax’s tests identify the amyloid beta 1-42 and tau biomarkers in cerebrospinal fluid (CSF) which are known and accepted biomarkers for AD.

Alzheimer’s Disease is currently the sixth leading cause of death in the U.S., affecting nearly 50 million patients worldwide, with 10 million new cases each year. Presently, no disease-modifying therapeutics exist, and the available drugs provide limited alleviation of symptoms. The use of tests to identify CSF biomarkers much sooner than previously available, will give clinicians the ability to more accurately identify AD and begin treatment sooner. Early detection of AD is also an important step in better understanding the disease.

The two biomarkers have been extensively studied for over 20 years, and are key indicators of the early stages of Alzheimer’s disease. Currently, evidence of early AD can only be determined by PET (positron emission tomography) imaging equipment such as can be found with Siemen’s PETNET Solutions, or biomarkers such as Saladax’s amyloid beta 1-42 and tau tests.

“We are very excited to be working with Siemens Healthineers to bring these important assays to the market,” said Sal Salamone, Ph.D., CEO of Saladax Biomedical, Inc. “Siemens is an ideal partner with a strong global position and high quality instrumentation.”

Under this non-exclusive agreement, Saladax will provide its proprietary raw materials, protocols, and intellectual property and Siemens will be responsible for the commercialization of both assays.

About Saladax Biomedical, Inc.

Saladax Biomedical is a leader in the development and deployment of high-quality diagnostic services and products to help physicians select and optimize the use of current and new pharmaceutical products, to improve treatment and positively impact the economics of care… because no two patients are alike.

Headquartered in Bethlehem, Pennsylvania, Saladax was founded in 2004 and is ISO 13485:2003 certified. For more information visit: www.saladax.com.

View source version on businesswire.com: http://www.businesswire.com/news/home/20170118005807/en/

Biotech company founder Sal Salamone honored as one of New Jersey’s top inventors

The Morning Call • November 2, 2016

The co-founder of a Bethlehem biomedical company can claim to be linked with Thomas Edison, Albert Einstein and countless other great innovators with ties to the Garden State.

Sal Salamone, CEO and president of Bethlehem-based Saladax Biomedical Inc., has been inducted into the New Jersey Inventors Hall of Fame. His award, for “luminary discoveries,” covers the following fields: oncology research, therapeutic diagnostics, health care and medical device services.

Salamone’s company makes a test to gauge the level of chemotherapy drugs in bloodstreams. The drug gauge addresses the issue of cancer patients absorbing pharmaceuticals at different rates.

c2tlrsexaaaswvj

“We will not fully achieve the promise of personalized medicine until we also ensure patients are receiving the correct amount of drug for their body,” Salamone said in a statement. “This is my life’s work and I am deeply honored to be recognized for it.”

Salamone, who grew up in central New Jersey, has more than 30 years of experience developing diagnostics, and has earned more than 140 U.S. or foreign patents. The Bethlehem resident worked nearly three decades for Roche Diagnostics before becoming senior vice president of research and development for OraSure Technologies Inc. in 2001.

Three years later, he co-founded Saladax Biomedical, which is based at Ben Franklin Technology Partners of Northeast Pennsylvania’s TechVentures building on Lehigh University’s Mountaintop campus.

Salamone joined nearly three dozen winners who were honored Oct. 27 during an awards banquet in Hoboken, N.J. The event honors inventors who hail from the Garden State, from graduate students beginning their careers to veteran innovators.